Renal Cell Carcinoma News and Research

RSS
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Combination immunotherapy shows better overall survival in kidney cancer patients

Combination immunotherapy shows better overall survival in kidney cancer patients

Penn researcher wins National Cancer Institute Outstanding Investigator Award

Penn researcher wins National Cancer Institute Outstanding Investigator Award

Review of kidney cancer incidence in California signals end of a trend

Review of kidney cancer incidence in California signals end of a trend

Combination therapy shows efficacy, safety in treating metastatic renal cell cancer

Combination therapy shows efficacy, safety in treating metastatic renal cell cancer

Experimental drug benefits some patients with advanced kidney cancer

Experimental drug benefits some patients with advanced kidney cancer

Blocking newly discovered cellular pathway could help control tumor growth

Blocking newly discovered cellular pathway could help control tumor growth

Researchers develop new mouse model that could lead to better treatment of kidney cancer

Researchers develop new mouse model that could lead to better treatment of kidney cancer

Rush clinical trial offers new immunotherapy combination to patients fighting kidney cancer

Rush clinical trial offers new immunotherapy combination to patients fighting kidney cancer

Phase 1 trial shows safety and tolerability of oncolytic HSV-1 for children, young adults with cancer

Phase 1 trial shows safety and tolerability of oncolytic HSV-1 for children, young adults with cancer

Stereotactic radiation provides effective, noninvasive treatment option for kidney cancer patients

Stereotactic radiation provides effective, noninvasive treatment option for kidney cancer patients

Mayo Clinic study shows surgery could more than double life expectancy for kidney cancer patients

Mayo Clinic study shows surgery could more than double life expectancy for kidney cancer patients

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

New discovery could lead to development of new cancer treatments

New discovery could lead to development of new cancer treatments

Breast cancer patient finds new hope with potentially revolutionary treatment

Breast cancer patient finds new hope with potentially revolutionary treatment

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

Researchers find new path to stop metastatic growth of cancer

Researchers find new path to stop metastatic growth of cancer

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer